Page last updated: 2024-08-24

rhodamine 123 and alpha-cyclodextrin

rhodamine 123 has been researched along with alpha-cyclodextrin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Li, X; Liu, M; Shi, Q; Xu, X; Zhang, J; Zhang, L; Zhang, X	1

Other Studies

1 other study(ies) available for rhodamine 123 and alpha-cyclodextrin

Article	Year
Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells. Biomaterials, 2015, Volume: 67 Topics: Acetylation; Adenosine Triphosphatases; alpha-Cyclodextrins; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cytoskeleton; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Membrane Potential, Mitochondrial; Nanomedicine; Nanoparticles; Neoplasms; Paclitaxel; Rhodamine 123	2015

Article

Year

Reversion of multidrug resistance by a pH-responsive cyclodextrin-derived nanomedicine in drug resistant cancer cells.

Biomaterials, 2015, Volume: 67

Topics: Acetylation; Adenosine Triphosphatases; alpha-Cyclodextrins; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cell Membrane; Cytoskeleton; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Endocytosis; Energy Metabolism; Humans; Hydrogen-Ion Concentration; Membrane Potential, Mitochondrial; Nanomedicine; Nanoparticles; Neoplasms; Paclitaxel; Rhodamine 123

2015